Universal Health Services, Inc. Names Darren Lehrich as Vice President of Investor Relations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 15 2025
0mins
Source: Newsfilter
New Appointment: Darren Lehrich has been appointed as Vice President of Investor Relations at Universal Health Services, Inc. (UHS), reporting to CFO Steve Filton.
Professional Background: Lehrich brings extensive experience in healthcare finance, having previously held leadership roles at Help at Home, Magellan Health, and American Renal Associates, along with 17 years as an equity research analyst.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UHS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UHS
Wall Street analysts forecast UHS stock price to rise
15 Analyst Rating
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 229.980
Low
190.00
Averages
248.00
High
302.00
Current: 229.980
Low
190.00
Averages
248.00
High
302.00
About UHS
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 359 inpatient facilities, and 60 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, physician recruitment services, and public relations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Universal Health Services Q4 2025 Earnings Highlights
- Revenue Growth: Universal Health Services (UHS) reported Q4 2025 revenue of $4.49 billion, reflecting a 9.1% year-over-year increase and surpassing the market expectation of $4.48 billion, indicating sustained growth potential in the healthcare sector.
- Earnings Performance: The quarterly EPS stood at $5.88, a significant rise from $4.92 in the same quarter last year, although it fell short of the analyst consensus estimate of $5.92, highlighting challenges in profitability.
- Market Reaction: Despite the revenue beat, the negative EPS surprise of -0.63% may dampen investor confidence, prompting a reassessment of UHS's future performance and competitive position in the healthcare industry.
- Industry Outlook: With the global semiconductor market projected to grow from $452 billion in 2021 to $971 billion by 2028, UHS's performance in healthcare may be influenced by broader technological trends, particularly with the surge in demand for artificial intelligence and the Internet of Things.
See More
Universal Health Services Q4 2025 Earnings Report Analysis
- Earnings Miss: Universal Health Services reported a Q4 non-GAAP EPS of $5.88, missing expectations by $0.03, indicating potential pressure on profitability that may affect investor confidence.
- Revenue Growth Constraints: Q4 revenue reached $4.49 billion, a 9.2% year-over-year increase, yet fell short of expectations by $20 million, reflecting intensified market competition and rising costs that hinder revenue growth.
- Annual Financial Outlook: For the year ending December 31, 2026, net revenues are projected between $18.417 billion and $18.789 billion, with adjusted EBITDA expected to range from $2.641 billion to $2.789 billion, indicating a cautious outlook from the company.
- Capital Expenditure Plans: Anticipated capital expenditures are between $950 million and $1.1 billion, demonstrating the company's ongoing commitment to facility expansion and upgrades despite profitability pressures.
See More
Universal Health Services Reports Strong 2025 Financial Results
- Revenue Growth: Universal Health Services reported net revenues of $4.486 billion in Q4 2025, a 9.1% increase from Q4 2024, indicating strong performance in the healthcare sector and likely boosting market confidence.
- Earnings Per Share Increase: The diluted earnings per share for Q4 2025 reached $7.06, up from $4.96 in Q4 2024, reflecting enhanced profitability that may attract more investor interest.
- Adjusted EBITDA Growth: The adjusted EBITDA for Q4 2025 was $678.7 million, a 10.4% increase from $614.6 million in Q4 2024, demonstrating significant achievements in cost control and operational efficiency.
- Positive Future Outlook: The company forecasts net revenues for 2026 to range from $18.417 billion to $18.789 billion, with adjusted EBITDA expected between $2.641 billion and $2.789 billion, showcasing confidence in future growth that may draw more investor attention.
See More
Analysis and Outlook: Exploring Claude Nine
- Market Recovery: Stocks made a significant recovery on Tuesday, nearly offsetting the losses experienced on Monday.
- Investor Sentiment: The rebound indicates a shift in investor sentiment following a period of decline.
- Economic Indicators: The recovery may be influenced by various economic indicators that are being closely monitored by analysts.
- Future Outlook: Analysts are assessing whether this trend will continue or if further volatility is expected in the market.
See More
Stocks to Keep an Eye on This Week: Nvidia, Warner Bros., Berkshire Hathaway, Home Depot, and Others
Market Performance: The Nasdaq Composite and S&P 500 indexes ended their multi-week losing streaks, increasing by 1.5% and 1.1%, respectively.
Supreme Court Ruling: A significant factor in the market rise was the Supreme Court's decision to strike down some of President Trump's tariffs.
White House Response: Despite the ruling, the White House announced plans to explore alternative methods to enforce its tariff policy.
Investor Sentiment: The combination of the court ruling and the White House's response influenced investor sentiment positively, contributing to the uptick in equities.
See More
Trump's New Tariff Plan Triggers Market Volatility
- Tariff Policy Shift: Following the Supreme Court ruling, Trump plans to impose a new 10% global tariff, which could lead to the U.S. needing to refund billions in tariffs to importers; the market reacted with initial gains followed by losses, reflecting investor uncertainty about future trade relations.
- Legal Challenge Outlook: The Supreme Court's ruling that Trump wrongfully invoked the International Emergency Economic Powers Act to implement tariffs pushes the refund issue back to lower courts, indicating that firms will face lengthy legal processes to obtain refunds, potentially impacting their cash flow and investment decisions.
- Cautious Market Sentiment: While geopolitical risks have not historically impacted the stock market significantly, investors may reduce exposure as stocks approach all-time highs, especially with the upcoming Nvidia earnings report raising concerns about potential disappointments, leading to heightened market tension.
- Economic Stimulus Expectations: Despite uncertainties, investors remain hopeful that the fiscal stimulus from last year's legislation will begin to take effect in the coming months, potentially alleviating signs of economic weakness and supporting long-term market growth.
See More
Universal Health Services Q4 2025 Earnings Highlights
- Revenue Growth: Universal Health Services (UHS) reported Q4 2025 revenue of $4.49 billion, reflecting a 9.1% year-over-year increase and surpassing the market expectation of $4.48 billion, indicating sustained growth potential in the healthcare sector.
- Earnings Performance: The quarterly EPS stood at $5.88, a significant rise from $4.92 in the same quarter last year, although it fell short of the analyst consensus estimate of $5.92, highlighting challenges in profitability.
- Market Reaction: Despite the revenue beat, the negative EPS surprise of -0.63% may dampen investor confidence, prompting a reassessment of UHS's future performance and competitive position in the healthcare industry.
- Industry Outlook: With the global semiconductor market projected to grow from $452 billion in 2021 to $971 billion by 2028, UHS's performance in healthcare may be influenced by broader technological trends, particularly with the surge in demand for artificial intelligence and the Internet of Things.
See More
Universal Health Services Q4 2025 Earnings Report Analysis
- Earnings Miss: Universal Health Services reported a Q4 non-GAAP EPS of $5.88, missing expectations by $0.03, indicating potential pressure on profitability that may affect investor confidence.
- Revenue Growth Constraints: Q4 revenue reached $4.49 billion, a 9.2% year-over-year increase, yet fell short of expectations by $20 million, reflecting intensified market competition and rising costs that hinder revenue growth.
- Annual Financial Outlook: For the year ending December 31, 2026, net revenues are projected between $18.417 billion and $18.789 billion, with adjusted EBITDA expected to range from $2.641 billion to $2.789 billion, indicating a cautious outlook from the company.
- Capital Expenditure Plans: Anticipated capital expenditures are between $950 million and $1.1 billion, demonstrating the company's ongoing commitment to facility expansion and upgrades despite profitability pressures.
See More
Universal Health Services Reports Strong 2025 Financial Results
- Revenue Growth: Universal Health Services reported net revenues of $4.486 billion in Q4 2025, a 9.1% increase from Q4 2024, indicating strong performance in the healthcare sector and likely boosting market confidence.
- Earnings Per Share Increase: The diluted earnings per share for Q4 2025 reached $7.06, up from $4.96 in Q4 2024, reflecting enhanced profitability that may attract more investor interest.
- Adjusted EBITDA Growth: The adjusted EBITDA for Q4 2025 was $678.7 million, a 10.4% increase from $614.6 million in Q4 2024, demonstrating significant achievements in cost control and operational efficiency.
- Positive Future Outlook: The company forecasts net revenues for 2026 to range from $18.417 billion to $18.789 billion, with adjusted EBITDA expected between $2.641 billion and $2.789 billion, showcasing confidence in future growth that may draw more investor attention.
See More
Analysis and Outlook: Exploring Claude Nine
- Market Recovery: Stocks made a significant recovery on Tuesday, nearly offsetting the losses experienced on Monday.
- Investor Sentiment: The rebound indicates a shift in investor sentiment following a period of decline.
- Economic Indicators: The recovery may be influenced by various economic indicators that are being closely monitored by analysts.
- Future Outlook: Analysts are assessing whether this trend will continue or if further volatility is expected in the market.
See More
Stocks to Keep an Eye on This Week: Nvidia, Warner Bros., Berkshire Hathaway, Home Depot, and Others
Market Performance: The Nasdaq Composite and S&P 500 indexes ended their multi-week losing streaks, increasing by 1.5% and 1.1%, respectively.
Supreme Court Ruling: A significant factor in the market rise was the Supreme Court's decision to strike down some of President Trump's tariffs.
White House Response: Despite the ruling, the White House announced plans to explore alternative methods to enforce its tariff policy.
Investor Sentiment: The combination of the court ruling and the White House's response influenced investor sentiment positively, contributing to the uptick in equities.
See More
Trump's New Tariff Plan Triggers Market Volatility
- Tariff Policy Shift: Following the Supreme Court ruling, Trump plans to impose a new 10% global tariff, which could lead to the U.S. needing to refund billions in tariffs to importers; the market reacted with initial gains followed by losses, reflecting investor uncertainty about future trade relations.
- Legal Challenge Outlook: The Supreme Court's ruling that Trump wrongfully invoked the International Emergency Economic Powers Act to implement tariffs pushes the refund issue back to lower courts, indicating that firms will face lengthy legal processes to obtain refunds, potentially impacting their cash flow and investment decisions.
- Cautious Market Sentiment: While geopolitical risks have not historically impacted the stock market significantly, investors may reduce exposure as stocks approach all-time highs, especially with the upcoming Nvidia earnings report raising concerns about potential disappointments, leading to heightened market tension.
- Economic Stimulus Expectations: Despite uncertainties, investors remain hopeful that the fiscal stimulus from last year's legislation will begin to take effect in the coming months, potentially alleviating signs of economic weakness and supporting long-term market growth.
See More
